Stock listing
NASDAQ:MTCR Metacrine Inc Stock
Follow Metacrine Inc into a list and get an email when it puts out news.
Delisted NASDAQ:MTCR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:MTCR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Metacrine Inc on 6ix
- Calls
- 1 call with a replay · 1 with a transcript · latest Mar 18, 2021
- Decks
- 3 decks · latest Sep 27, 2022
Events
| Call | When | Status |
|---|---|---|
| Metacrine (MTCR) Q4 2020 Earnings Call | Thu, Mar 18, 2021 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (September 2022) | Merger or acquisition | 32 slides | Sep 27, 2022 |
| Merger or Acquisition (September 2022) | Merger or acquisition | 9 slides | Sep 6, 2022 |
| Investor Day (September 2021) | Investor day | 85 slides | Sep 15, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kristina Burow Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Jan 30, 2025); Boundless Bio, Inc. (Director · Since at least Mar 27, 2024); Neumora Therapeutics, Inc. (Director · Since at least Sep 14, 2023); Scholar Rock Holding Corporation (Director · Since at least May 23, 2018); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Jun 6, 2023 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 21, 2020 · Past); Gossamer Bio, Inc. (Director · Feb 7, 2019 – Jun 8, 2023 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 24, 2021 · Past); Receptos Inc (Director · Aug 25, 2015 – Aug 25, 2015 · Past) | Director · Sep 15, 2020 – May 24, 2021 · Past |
| Amir Nashat Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Morphic Holding Inc (Director · Jun 26, 2019 – Aug 16, 2024 · Past); Scholar Rock Holding Corporation (Director · May 23, 2018 – May 9, 2024 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 1, 2022 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 14, 2019 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 15, 2018 · Past); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Jul 31, 2019 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past); Receptos Inc (Director · May 8, 2013 – Jun 3, 2014 · Past) | Director · Sep 15, 2020 – May 18, 2022 · Past |
| Carol G. Gallagher Other companies: TRex Bio, Inc. (Lead Independent Director · Since at least Nov 5, 2026); PMV Pharmaceuticals, Inc. (Director · Since at least Nov 3, 2022); Atara Biotherapeutics, Inc. (Director · Since at least Jun 27, 2019); Certara, Inc. (Director · Jun 15, 2021 – Jun 15, 2021 · Past); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Turning Point Therapeutics Inc (Director · Jul 24, 2019 – Aug 17, 2022 · Past); Tempest Therapeutics, Inc. (Director · Jun 20, 2019 – Jun 22, 2020 · Past) | Director · Sep 15, 2020 – Sep 15, 2020 · Past |
| Richard Heyman Other companies: Enliven Therapeutics, Inc. (Director · Since at least Feb 23, 2023); PMV Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2020); ORIC Pharmaceuticals, Inc. (Chairman · Since at least Apr 23, 2020); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Kineta Inc. (Director · Dec 22, 2020 – Jun 2, 2021 · Past); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past); Gritstone bio, Inc. (Director · Sep 27, 2018 – Jun 17, 2022 · Past) | Director · Sep 15, 2020 – May 18, 2022 · Past |
| Preston Klassen Other companies: Regulus Therapeutics Inc (President & Head of R & D, Director · Since at least Jun 12, 2023); Zura Bio Limited (President and COO · Mar 20, 2023 – Mar 20, 2023 · Past); Arena Pharmaceuticals Inc (EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past); Histogen Inc (Director · Feb 7, 2014 – Jun 27, 2019 · Past); Orexigen Therapeutics Inc (EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past) | Director · Sep 15, 2020 – Mar 23, 2023 · Past |
| Catherine Chai-zon Lee Other companies: TFF Pharmaceuticals Inc (Director · Dec 1, 2023 – Jul 3, 2024 · Past); Senomyx Inc (Sr. V.P. Gen. Counsel & Sec. · Mar 23, 2015 – Nov 2, 2018 · Past); Outdoor Channel Holdings Inc (General Counsel · Feb 1, 2012 – May 17, 2013 · Past) | EVP, Gen. Counsel & Secretary · Nov 5, 2020 – May 5, 2021 · Past |
| Hubert C. Chen Other companies: Viking Therapeutics, Inc. (Chief Medical Officer · Since at least Jun 1, 2026); Forte Biosciences, Inc. (See remarks · Jun 7, 2022 – Jan 1, 2024 · Past); Pfenex Inc (See Remarks · Nov 3, 2014 – Feb 1, 2018 · Past) | Chief Medical Officer · Sep 15, 2020 – May 20, 2021 · Past |
| Jeffrey David Jonker Other companies: Theravance Biopharma, Inc. (Senior VP, Corp. & Bus. Dev. · May 14, 2014 – Jun 3, 2014 · Past); Innoviva, Inc. (Senior VP, Corp. & Bus. Dev. · Oct 14, 2013 – Oct 22, 2013 · Past) | Director · Mar 17, 2021 – May 18, 2022 · Past |
| John McHutchison Other companies: Assembly Biosciences, Inc. (Director · Since at least Aug 6, 2019); Gilead Sciences, Inc. (Chief Scientific Off/HeadR&D · Apr 23, 2018 – Feb 6, 2019 · Past) | Director · Sep 15, 2020 – May 18, 2022 · Past |
| Julia C Owens Other companies: Tempest Therapeutics, Inc. (Executive Chair, Director · Dec 7, 2018 – Mar 17, 2021 · Past) | Director · Apr 1, 2021 – May 18, 2022 · Past |
All 13 people
| Person | Seat |
|---|---|
| Michael York Other companies: PhaseBio Pharmaceuticals Inc (VP, Corporate Development · Oct 17, 2018 – May 20, 2021 · Past) | Chief Business Officer · Feb 18, 2022 – Jan 26, 2023 · Past |
| Ronald M Evans | Director · Sep 15, 2020 – May 18, 2022 · Past |
| Trisha Millican | Chief Financial Officer · Sep 15, 2020 – May 5, 2021 · Past |
Log in to ask 6ix AI your own questions about Metacrine Inc.